Blog

A former VP and associate general counsel for GSK, is back in the courthouse. After being indicted for obstructing an official proceeding, concealing and falsifying records and making false statements to the FDA back in November 2010, she was able to get the charges dismissed because prosecutors “misinstructed” a grand juror as to a question about a central legal point. However, the judge’s dismissal left open the possibility of re-indicting Ms. Stevens. This has now happened.
Read more: http://www.modernhealthcare.com/article/20110414/NEWS/304149960/&cslet=UnhOY2lLWDlLL09ZK2lzMW9hV25UdkJ2cCtycXVHUE8=

With all the focus on nuclear plants from the recent earthquake and tsunami in Japan, a whistleblower at one of California’s nuclear plants has stepped forward with claims of retaliation after reporting safety concerns.

Read more:http://www.ottawacitizen.com/technology/Whistleblower+files+suit+against+nuclear+plant/4565888/story.html

With increasing drug violence, the Mexican Attorney General’s office is instituting a new program for whistleblowers on money-laundering. The whistleblowers stand to collect up to one fourth of the total recovery.

Read more: http://www.reuters.com/article/2011/04/06/mexico-whistleblower-idUSN0620658120110406

The 4th Circuit Court of Appeals heard arguments about whether the False Claims Act provision that seals lawsuits from public disclosure violates the First Amendment. The U.S. Court of Appeals upheld the lower court’s decision that extending the 60-day seal period does not violate the constitution.

In Cafasso v. General Dynamics, the Ninth Circuit Court of Appeals ruled that FCA complaints can not merely allege “unsavory conduct…[U]nsavory conduct is not, without more, actionable under the [False Claims Act].” The court goes on to say that FCA actions must “state with particularity the circumstances constitute fraud or mistake,” as well as, “plead plausible allegations.” The court’s decision forces FCA cases to clear a higher bar.